Steven R Hagen Insider Trading $AMRI ALBANY MOLECULAR RESEARCH INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Steven R Hagen.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Steven R Hagen. Steven R Hagen is Sr VP Pharmaceutical Dev & Mfg in ALBANY MOLECULAR RESEARCH INC ($AMRI) and SVP Manufacturing & Pharmaceut in ALBANY MOLECULAR RESEARCH INC ($AMRI) and SVP Pharmaceutical Dev & Mfg in ALBANY MOLECULAR RESEARCH INC ($AMRI) and VP Pharmaceutical Dev & Mfg in ALBANY MOLECULAR RESEARCH INC ($AMRI).
Steven R Hagen in ALBANY MOLECULAR RESEARCH INC
Trading Symbol: AMRIIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Steven R Hagen: SVP Manufacturing & Pharmaceut, SVP Pharmaceutical Dev & Mfg, Sr VP Pharmaceutical Dev & Mfg, VP Pharmaceutical Dev & Mfg
Holdings: 43,655 shares
Current Value: $804,998
Latest Transaction: Sep 05 2017
$AMRI Market Capitalization: $765.67M
$AMRI Previous Close: $18.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Steven R Hagen in ALBANY MOLECULAR RESEARCH INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | D | 18.41 | 29,412 | 541,475 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | D | 15.77 | 22,889 | 360,960 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | D | 17.05 | 16,280 | 277,574 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | D | 10.43 | 20,000 | 208,600 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | D | 5.99 | 3,750 | 22,463 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | D | 5.99 | 3,750 | 22,463 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | D | 5.99 | 7,500 | 44,925 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | D | 2.93 | 3,750 | 10,988 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | D | 21.75 | 43,655 | 949,496 | 0 | 43.7 K to 0 (-100.00 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Grant | A | 0.00 | 3,138 | 0 | 43,655 | 40.5 K to 43.7 K (+7.74 %) |
Mar 06 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Payment of Exercise | F | 14.52 | 350 | 5,082 | 40,517 | 40.9 K to 40.5 K (-0.86 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | A | 18.41 | 29,412 | 541,475 | 29,412 | |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Grant | A | 0.00 | 4,484 | 0 | 40,867 | 36.4 K to 40.9 K (+12.32 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Grant | A | 0.00 | 5,975 | 0 | 36,383 | 30.4 K to 36.4 K (+19.65 %) |
Feb 07 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Payment of Exercise | F | 18.52 | 488 | 9,038 | 30,408 | 30.9 K to 30.4 K (-1.58 %) |
Feb 07 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Payment of Exercise | F | 18.52 | 664 | 12,297 | 30,896 | 31.6 K to 30.9 K (-2.10 %) |
Feb 07 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Payment of Exercise | F | 18.52 | 2,291 | 42,429 | 31,560 | 33.9 K to 31.6 K (-6.77 %) |
Feb 01 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Payment of Exercise | F | 18.11 | 531 | 9,616 | 33,851 | 34.4 K to 33.9 K (-1.54 %) |
Feb 01 2017 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Payment of Exercise | F | 18.11 | 531 | 9,616 | 34,382 | 34.9 K to 34.4 K (-1.52 %) |
Dec 01 2016 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | M | 13.20 | 9,000 | 118,800 | 0 | |
Dec 01 2016 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | S | 16.71 | 9,000 | 150,390 | 34,913 | 43.9 K to 34.9 K (-20.50 %) |
Dec 01 2016 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Buy | M | 13.20 | 9,000 | 118,800 | 43,913 | 34.9 K to 43.9 K (+25.78 %) |
Nov 10 2016 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | S | 16.79 | 785 | 13,180 | 34,913 | 35.7 K to 34.9 K (-2.20 %) |
Nov 03 2016 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Payment of Exercise | F | 15.09 | 465 | 7,017 | 35,698 | 36.2 K to 35.7 K (-1.29 %) |
Aug 10 2016 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | S | 15.29 | 1,401 | 21,421 | 36,163 | 37.6 K to 36.2 K (-3.73 %) |
May 16 2016 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | S | 12.77 | 2,361 | 30,150 | 37,564 | 39.9 K to 37.6 K (-5.91 %) |
Mar 04 2016 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Payment of Exercise | F | 15.33 | 340 | 5,212 | 39,925 | 40.3 K to 39.9 K (-0.84 %) |
Feb 19 2016 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | D | 0.00 | 1,250 | 0 | 40,265 | 41.5 K to 40.3 K (-3.01 %) |
Feb 19 2016 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Payment of Exercise | F | 15.37 | 451 | 6,932 | 41,515 | 42 K to 41.5 K (-1.07 %) |
Feb 08 2016 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | A | 15.77 | 22,889 | 360,960 | 22,889 | |
Feb 08 2016 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Grant | A | 15.77 | 9,988 | 157,511 | 41,966 | 52 K to 42 K (-19.22 %) |
Feb 05 2016 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Payment of Exercise | F | 16.16 | 664 | 10,730 | 31,978 | 32.6 K to 32 K (-2.03 %) |
Feb 01 2016 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Payment of Exercise | F | 15.97 | 529 | 8,448 | 32,642 | 33.2 K to 32.6 K (-1.59 %) |
Feb 01 2016 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Payment of Exercise | F | 15.97 | 529 | 8,448 | 33,171 | 33.7 K to 33.2 K (-1.57 %) |
Nov 04 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Grant | A | 19.16 | 5,000 | 95,800 | 33,700 | 28.7 K to 33.7 K (+17.42 %) |
Aug 17 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | M | 13.20 | 1,000 | 13,200 | 9,000 | |
Aug 17 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | S | 20.45 | 1,000 | 20,450 | 28,700 | 29.7 K to 28.7 K (-3.37 %) |
Aug 17 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Buy | M | 13.20 | 1,000 | 13,200 | 29,700 | 28.7 K to 29.7 K (+3.48 %) |
Aug 10 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | M | 13.20 | 5,000 | 66,000 | 10,000 | |
Aug 10 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | S | 21.06 | 5,000 | 105,300 | 28,700 | 33.7 K to 28.7 K (-14.84 %) |
Aug 10 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Buy | M | 13.20 | 5,000 | 66,000 | 33,700 | 28.7 K to 33.7 K (+17.42 %) |
Jun 09 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | M | 10.43 | 5,000 | 52,150 | 20,000 | |
Jun 09 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | S | 19.99 | 5,000 | 99,950 | 28,700 | 33.7 K to 28.7 K (-14.84 %) |
Jun 09 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Buy | M | 10.43 | 5,000 | 52,150 | 33,700 | 28.7 K to 33.7 K (+17.42 %) |
Jun 05 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | S | 19.58 | 787 | 15,409 | 28,700 | 29.5 K to 28.7 K (-2.67 %) |
Jun 04 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | M | 5.25 | 3,750 | 19,688 | 0 | |
Jun 04 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | S | 19.39 | 3,750 | 72,713 | 29,487 | 33.2 K to 29.5 K (-11.28 %) |
Jun 04 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Buy | M | 5.25 | 3,750 | 19,688 | 33,237 | 29.5 K to 33.2 K (+12.72 %) |
Jun 04 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | D | 0.00 | 1,250 | 0 | 29,487 | 30.7 K to 29.5 K (-4.07 %) |
Jun 04 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Payment of Exercise | F | 0.00 | 463 | 0 | 30,737 | 31.2 K to 30.7 K (-1.48 %) |
May 11 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | M | 11.21 | 7,500 | 84,075 | 0 | |
May 11 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | M | 8.90 | 7,000 | 62,300 | 0 | |
May 11 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | S | 19.20 | 7,500 | 144,000 | 31,200 | 38.7 K to 31.2 K (-19.38 %) |
May 11 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Buy | M | 11.21 | 7,500 | 84,075 | 38,700 | 31.2 K to 38.7 K (+24.04 %) |
May 11 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | S | 19.35 | 7,000 | 135,450 | 31,200 | 38.2 K to 31.2 K (-18.32 %) |
May 11 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Buy | M | 8.90 | 7,000 | 62,300 | 38,200 | 31.2 K to 38.2 K (+22.44 %) |
Mar 19 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | S | 18.53 | 3,500 | 64,855 | 27,700 | 31.2 K to 27.7 K (-11.22 %) |
Mar 16 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | S | 18.79 | 441 | 8,286 | 31,200 | 31.6 K to 31.2 K (-1.39 %) |
Mar 12 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Sell | S | 18.30 | 721 | 13,194 | 31,641 | 32.4 K to 31.6 K (-2.23 %) |
Mar 10 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Payment of Exercise | F | 0.00 | 259 | 0 | 32,362 | 32.6 K to 32.4 K (-0.79 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Option Exercise | A | 17.05 | 16,280 | 277,574 | 16,280 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Manufacturing & ... | Grant | A | 17.05 | 7,530 | 128,387 | 32,621 | 25.1 K to 32.6 K (+30.01 %) |
Feb 25 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Option Exercise | M | 5.99 | 3,750 | 22,463 | 15,000 | |
Feb 25 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Sell | S | 16.22 | 3,750 | 60,825 | 25,091 | 28.8 K to 25.1 K (-13.00 %) |
Feb 25 2015 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | SVP Pharmaceutical ... | Buy | M | 5.99 | 3,750 | 22,463 | 28,841 | 25.1 K to 28.8 K (+14.95 %) |
Dec 04 2013 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Option Exercise | M | 2.93 | 2,500 | 7,325 | 27,500 | |
Dec 04 2013 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Sell | S | 10.93 | 2,500 | 27,325 | 27,414 | 29.9 K to 27.4 K (-8.36 %) |
Dec 04 2013 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Buy | M | 2.93 | 2,500 | 7,325 | 29,914 | 27.4 K to 29.9 K (+9.12 %) |
Nov 22 2013 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Sell | S | 11.55 | 2,300 | 26,565 | 27,414 | 29.7 K to 27.4 K (-7.74 %) |
Nov 06 2013 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Payment of Exercise | F | 0.00 | 362 | 0 | 29,714 | 30.1 K to 29.7 K (-1.20 %) |
Jun 04 2013 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Payment of Exercise | F | 0.00 | 454 | 0 | 30,076 | 30.5 K to 30.1 K (-1.49 %) |
Jun 04 2013 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Sell | D | 0.00 | 1,250 | 0 | 30,530 | 31.8 K to 30.5 K (-3.93 %) |
May 31 2013 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Sell | S | 11.26 | 800 | 9,008 | 31,780 | 32.6 K to 31.8 K (-2.46 %) |
May 13 2013 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Sell | S | 10.40 | 1,200 | 12,480 | 32,580 | 33.8 K to 32.6 K (-3.55 %) |
Mar 20 2013 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Sell | S | 9.91 | 180 | 1,784 | 33,780 | 34 K to 33.8 K (-0.53 %) |
Mar 20 2013 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Sell | S | 9.98 | 249 | 2,485 | 33,960 | 34.2 K to 34 K (-0.73 %) |
Mar 14 2013 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Sell | S | 10.75 | 677 | 7,278 | 34,209 | 34.9 K to 34.2 K (-1.94 %) |
Mar 11 2013 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Sell | S | 9.56 | 1,000 | 9,560 | 34,886 | 35.9 K to 34.9 K (-2.79 %) |
Feb 26 2013 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Sell | S | 8.18 | 984 | 8,049 | 35,886 | 36.9 K to 35.9 K (-2.67 %) |
Feb 21 2013 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Sell | S | 7.89 | 1,000 | 7,890 | 36,870 | 37.9 K to 36.9 K (-2.64 %) |
Feb 04 2013 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Option Exercise | A | 5.99 | 30,000 | 179,700 | 30,000 | |
Feb 04 2013 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Grant | A | 5.99 | 10,000 | 59,900 | 37,870 | 27.9 K to 37.9 K (+35.88 %) |
Nov 06 2012 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Sell | S | 3.51 | 372 | 1,306 | 27,870 | 28.2 K to 27.9 K (-1.32 %) |
Aug 27 2012 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | S | 3.22 | 1,000 | 3,220 | 28,242 | 29.2 K to 28.2 K (-3.42 %) |
Aug 13 2012 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | S | 3.00 | 3,000 | 9,000 | 29,242 | 32.2 K to 29.2 K (-9.30 %) |
Jun 12 2012 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | D | 0.00 | 1,250 | 0 | 32,242 | 33.5 K to 32.2 K (-3.73 %) |
Jun 07 2012 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | S | 2.28 | 504 | 1,149 | 33,492 | 34 K to 33.5 K (-1.48 %) |
May 16 2012 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | S | 3.01 | 2,400 | 7,224 | 33,996 | 36.4 K to 34 K (-6.59 %) |
Mar 21 2012 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | S | 2.80 | 205 | 574 | 36,396 | 36.6 K to 36.4 K (-0.56 %) |
Mar 21 2012 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | S | 2.75 | 873 | 2,401 | 36,601 | 37.5 K to 36.6 K (-2.33 %) |
Mar 08 2012 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | S | 2.66 | 91 | 242 | 37,474 | 37.6 K to 37.5 K (-0.24 %) |
Feb 21 2012 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Option Exercise | A | 2.93 | 30,000 | 87,900 | 30,000 | |
Feb 21 2012 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Grant | A | 2.93 | 10,000 | 29,300 | 37,565 | 27.6 K to 37.6 K (+36.28 %) |
Nov 14 2011 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | S | 2.62 | 382 | 1,001 | 27,565 | 27.9 K to 27.6 K (-1.37 %) |
Nov 08 2011 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | S | 3.11 | 1,139 | 3,542 | 27,947 | 29.1 K to 27.9 K (-3.92 %) |
Jun 06 2011 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Option Exercise | A | 5.25 | 30,000 | 157,500 | 30,000 | |
Jun 06 2011 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Grant | A | 5.25 | 10,000 | 52,500 | 29,086 | 19.1 K to 29.1 K (+52.39 %) |
May 12 2011 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | S | 4.84 | 198 | 958 | 19,086 | 19.3 K to 19.1 K (-1.03 %) |
Mar 28 2011 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | S | 4.18 | 617 | 2,579 | 19,284 | 19.9 K to 19.3 K (-3.10 %) |
Mar 28 2011 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | S | 4.46 | 87 | 388 | 19,901 | 20 K to 19.9 K (-0.44 %) |
Dec 06 2010 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | S | 5.20 | 2,000 | 10,400 | 19,988 | 22 K to 20 K (-9.10 %) |
Nov 23 2010 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | S | 5.77 | 887 | 5,118 | 21,988 | 22.9 K to 22 K (-3.88 %) |
Nov 23 2010 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | S | 6.09 | 355 | 2,162 | 22,875 | 23.2 K to 22.9 K (-1.53 %) |
Mar 22 2010 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Option Exercise | A | 8.90 | 2,100 | 18,690 | 10,500 | |
Mar 22 2010 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Option Exercise | A | 8.90 | 2,100 | 18,690 | 8,400 | |
Mar 22 2010 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Option Exercise | A | 8.90 | 6,300 | 56,070 | 6,300 | |
Mar 22 2010 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Grant | A | 8.90 | 3,500 | 31,150 | 23,489 | 20 K to 23.5 K (+17.51 %) |
Mar 10 2010 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | S | 8.83 | 259 | 2,287 | 19,730 | 20 K to 19.7 K (-1.30 %) |
Nov 20 2009 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | S | 8.05 | 1,500 | 12,075 | 19,989 | 21.5 K to 20 K (-6.98 %) |
Nov 16 2009 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | S | 8.47 | 2,000 | 16,940 | 21,489 | 23.5 K to 21.5 K (-8.51 %) |
Aug 06 2009 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | S | 8.79 | 900 | 7,911 | 23,489 | 24.4 K to 23.5 K (-3.69 %) |
Mar 18 2009 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Option Exercise | A | 8.31 | 2,100 | 17,451 | 10,500 | |
Mar 18 2009 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Option Exercise | A | 8.31 | 2,100 | 17,451 | 8,400 | |
Mar 18 2009 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Option Exercise | A | 8.31 | 6,300 | 52,353 | 6,300 | |
Mar 18 2009 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Grant | A | 8.31 | 3,500 | 29,085 | 24,389 | 20.9 K to 24.4 K (+16.76 %) |
Feb 12 2009 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | S | 10.49 | 2,000 | 20,980 | 20,889 | 22.9 K to 20.9 K (-8.74 %) |
Nov 21 2008 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | S | 8.96 | 2,400 | 21,504 | 22,889 | 25.3 K to 22.9 K (-9.49 %) |
Nov 19 2008 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Sell | S | 9.72 | 2,711 | 26,351 | 25,289 | 28 K to 25.3 K (-9.68 %) |
Nov 04 2008 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Option Exercise | A | 13.20 | 3,000 | 39,600 | 15,000 | |
Nov 04 2008 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Option Exercise | A | 13.20 | 3,000 | 39,600 | 12,000 | |
Nov 04 2008 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Option Exercise | A | 13.20 | 9,000 | 118,800 | 9,000 | |
Nov 04 2008 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | VP Pharmaceutical D ... | Grant | A | 13.20 | 5,000 | 66,000 | 28,000 | 23 K to 28 K (+21.74 %) |
Page: 1